<DOC>
	<DOCNO>NCT00589992</DOCNO>
	<brief_summary>To test hypothesis localize functional reentry maintains Afib human , ibutilide administer intravenously patient undergo Afib ablation . The hypothesis study ibutilide decrease high frequency signal observe Afib suggest presence micro reentrant circuit basic mechanism Afib , especially paroxysmal Afib group . The potential difference response ibutilide patient paroxysmal versus persistent Afib may show difference underlie mechanism Afib two group .</brief_summary>
	<brief_title>Ibutilide Administration During Pulmonary Vein Ablation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Ibutilide</mesh_term>
	<criteria>patient schedule atrial fibrillation radio frequency ablation paroxysmal , permanent symptomatic atrial fibrillation refractory conventional treatment symptomatic atrial fibrillation want desire take medication undergo cardioversion patient antiarrhythmic discontinue 5 half lifes prior procedure except Amiodarone patient recent major hemorrhage ( within 6 month ) patient coagulopathy patient pregnant breast feed patient acute congestive heart failure patient hypokalemia hyperkalemia patient prolong QTc &gt; 440mms patient polymorphic ventricular tachycardia secondary antiarrhythmic class III class I patient leave ventricular dysfunction &lt; 40 % patient history recent MI ( &lt; 1 month ) patient history angioplasty &lt; 1 month patient history coronary artery bypass graft surgery &lt; 3 month . patient history chronic renal failure creatinine clearance &lt; 30ml/m patient history stroke &lt; 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>